Sabra Health Care REIT Key Executives

This section highlights Sabra Health Care REIT's key executives, including their titles and compensation details.

Unlock Executive Information

Upgrade to access executive details

Upgrade Now

Find Contacts at Sabra Health Care REIT

(Showing 0 of )

Unlock Team Information

Upgrade to access team member details

Upgrade Now

Sabra Health Care REIT Earnings

This section highlights Sabra Health Care REIT's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.

Next Earnings Date

Date: May 06, 2025
Time: After Market
Est. EPS: $0.17
Status: Unconfirmed

Last Earnings Results

Date: February 19, 2025
EPS: $0.36
Est. EPS: $0.36
Revenue: $182.35M

Earnings Call Transcripts

Transcript Quarter Year Date Estimated EPS Actual EPS
Read Transcript Q4 2024 2025-02-20 N/A N/A
Read Transcript Q3 2024 2024-11-01 N/A N/A
Read Transcript Q2 2024 2024-08-08 N/A N/A
Read Transcript Q1 2024 2024-05-09 N/A N/A
Read Transcript Q4 2023 2024-02-28 N/A N/A
Read Transcript Q3 2023 2023-11-07 N/A N/A
Read Transcript Q2 2023 2023-08-08 N/A N/A
Read Transcript Q1 2023 2023-05-04 N/A N/A

Sabra Health Care REIT, Inc. (SBRA)

As of March 31, 2022, Sabra's investment portfolio included 416 real estate properties held for investment. This consists of (i) 279 Skilled Nursing/Transitional Care facilities, (ii) 59 Senior Housing communities (Senior Housing - Leased), (iii) 50 Senior Housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 13 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a sales-type lease, 16 investments in loans receivable (consisting of (i) two mortgage loans, (ii) one construction loan and (iii) 13 other loans), seven preferred equity investments and one investment in an unconsolidated joint venture. As of March 31, 2022, Sabra's real estate properties held for investment included 41,445 beds/units, spread across the United States and Canada.

Real Estate REIT - Healthcare Facilities

$17.54

Stock Price

$4.17B

Market Cap

50

Employees

Irvine, CA

Location

Financial Statements

Access annual & quarterly financial statements for Sabra Health Care REIT, including income statements, balance sheets, and cash flow statements..

Annual Income Statement

Breakdown December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Revenue $703.24M $647.51M $624.81M $569.54M $598.57M
Cost of Revenue $227.09M $378.33M $162.61M $141.20M $131.55M
Gross Profit $476.15M $269.18M $462.20M $428.34M $467.02M
Gross Profit Ratio 67.71% 41.60% 73.97% 75.20% 78.02%
Research and Development Expenses $- $- $-0 $-0 $0
General and Administrative Expenses $50.07M $47.47M $39.57M $34.67M $32.76M
Selling and Marketing Expenses $- $- $- $- $-
Selling General and Administrative Expenses $50.07M $47.47M $39.57M $34.67M $32.76M
Other Expenses $426.08M $- $187.92M $182.93M $178.59M
Operating Expenses $476.15M $42.45M $227.50M $217.59M $211.35M
Cost and Expenses $703.24M $420.78M $390.11M $358.80M $342.90M
Interest Income $- $- $105.57M $98.65M $100.52M
Interest Expense $115.27M $112.96M $105.47M $98.63M $100.42M
Depreciation and Amortization $169.62M $183.09M $375.43M $358.70M $370.42M
EBITDA $412.61M $311.81M $323.35M $166.21M $417.96M
EBITDA Ratio 58.67% 48.15% 51.75% 34.77% 69.83%
Operating Income $- $221.52M $135.57M $19.04M $241.22M
Operating Income Ratio 0.00% 34.21% 21.70% 3.34% 40.30%
Total Other Income Expenses Net $127.72M $-205.76M $-311.06M $-322.16M $-118.79M
Income Before Tax $127.72M $15.76M $-76.36M $-111.41M $139.13M
Income Before Tax Ratio 18.16% 2.43% -12.22% -19.56% 23.24%
Income Tax Expense $1.00M $2.00M $1.24M $1.84M $710.00K
Net Income $126.71M $13.76M $-77.61M $-113.26M $138.42M
Net Income Ratio 18.02% 2.12% -12.42% -19.89% 23.12%
EPS $0.54 $0.06 $-0.34 $-0.52 $0.67
EPS Diluted $0.54 $0.06 $-0.34 $-0.52 $0.67
Weighted Average Shares Outstanding 233.50M 231.20M 230.95M 219.07M 206.22M
Weighted Average Shares Outstanding Diluted 236.05M 232.79M 230.95M 219.07M 207.25M
SEC Filing Source Source Source Source Source


Breakdown December 31, 2024 September 30, 2024 June 30, 2024 March 31, 2024 December 31, 2023 September 30, 2023 June 30, 2023 March 31, 2023 December 31, 2022 September 30, 2022 June 30, 2022 March 31, 2022 December 31, 2021 September 30, 2021 June 30, 2021 March 31, 2021 December 31, 2020 September 30, 2020 June 30, 2020 March 31, 2020
Revenue $182.35M $178.00M $178.53M $172.20M $164.38M $161.63M $161.17M $161.32M $164.99M $140.76M $155.96M $163.10M $135.66M $128.59M $152.93M $152.37M $152.05M $143.25M $153.92M $149.35M
Cost of Revenue $59.84M $48.49M $96.43M $96.91M $92.75M $48.83M $48.73M $47.80M $43.80M $41.83M $38.88M $38.12M $37.38M $35.84M $33.90M $34.08M $33.10M $32.99M $33.30M $32.16M
Gross Profit $122.51M $129.51M $82.10M $75.29M $71.63M $112.80M $112.43M $113.52M $121.19M $98.94M $117.08M $124.99M $98.27M $92.75M $119.03M $118.28M $118.96M $110.26M $120.62M $117.18M
Gross Profit Ratio 67.18% 72.80% 46.00% 43.70% 43.60% 69.80% 69.80% 70.40% 73.50% 70.30% 75.10% 76.60% 72.40% 72.10% 77.80% 77.60% 78.23% 76.97% 78.36% 78.46%
Research and Development Expenses $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
General and Administrative Expenses $13.03M $12.40M $12.74M $11.89M $16.68M $10.76M $9.53M $10.50M $30.93M $9.68M $8.65M $10.40M $34.67M $8.68M $8.81M $8.94M $32.76M $7.22M $8.67M $8.76M
Selling and Marketing Expenses $- $- $- $- $- $- $- $- $-20.07M $- $- $- $-26.43M $- $- $- $-24.65M $- $- $-
Selling General and Administrative Expenses $13.03M $12.40M $12.74M $11.89M $16.68M $10.76M $9.53M $10.50M $10.85M $9.68M $8.65M $10.40M $8.24M $8.68M $8.81M $8.94M $8.11M $7.22M $8.67M $8.76M
Other Expenses $109.48M $- $78.00K $-14.65M $-1.69M $2.23M $-9.96M $52.62M $50.08M $994.00K $44.90M $45.73M $-13.00K $277.00K $-24.00K $133.00K $-154.00K $115.00K $-66.00K $2.26M
Operating Expenses $122.51M $12.40M $54.26M $14.65M $1.69M $54.33M $54.10M $63.12M $60.93M $56.89M $53.55M $56.13M $55.36M $53.70M $53.19M $55.34M $53.41M $51.34M $53.00M $53.60M
Cost and Expenses $182.35M $60.89M $108.91M $111.56M $94.44M $103.16M $102.84M $110.93M $104.73M $98.71M $92.43M $94.24M $92.75M $89.54M $87.09M $89.42M $86.51M $84.33M $86.31M $85.76M
Interest Income $- $- $- $- $15.60M $28.16M $28.33M $28.54M $28.00M $- $- $- $- $- $- $- $- $- $- $-
Interest Expense $28.08M $29.47M $29.31M $28.41M $43.54M $28.16M $28.33M $28.54M $27.90M $27.07M $25.53M $24.97M $25.68M $24.24M $24.27M $24.44M $24.52M $24.90M $25.29M $25.70M
Depreciation and Amortization $42.31M $42.72M $41.68M $42.91M $42.88M $43.24M $44.14M $52.83M $49.93M $47.43M $45.17M $45.26M $45.08M $45.05M $44.49M $44.38M $44.16M $44.21M $44.20M $44.17M
EBITDA $117.47M $101.71M $108.81M $100.41M $112.82M $101.07M $101.82M $102.73M $-36.11M $-3.22M $104.01M $111.39M $46.93M $244.18M $-59.46M $102.31M $114.17M $107.10M $99.58M $106.19M
EBITDA Ratio 64.42% 57.14% 62.34% 60.13% 68.63% 63.91% 63.18% 63.68% 13.26% 61.16% 66.69% 68.29% 55.08% 62.49% -38.90% 67.24% 69.70% 74.00% 64.72% 71.21%
Operating Income $- $64.52M $69.62M $60.64M $69.94M $148.85M $57.67M $49.90M $-28.06M $37.67M $58.84M $66.13M $1.85M $39.05M $65.84M $62.95M $65.55M $58.92M $67.61M $63.59M
Operating Income Ratio 0.00% 36.25% 38.99% 35.21% 42.55% 92.09% 35.79% 30.93% -17.01% 26.76% 37.73% 40.54% 1.37% 30.37% 43.05% 41.31% 43.11% 41.13% 43.93% 42.58%
Total Other Income Expenses Net $47.08M $-35.00M $-42.72M $-33.93M $-52.29M $-73.12M $-36.16M $-58.32M $-83.92M $-83.09M $-43.94M $-25.37M $-25.68M $-21.68M $-197.89M $-23.79M $-29.06M $-26.57M $-25.32M $-25.76M
Income Before Tax $47.08M $29.52M $24.41M $26.71M $17.65M $-14.65M $21.51M $-8.76M $-84.82M $-49.48M $17.06M $40.89M $-23.82M $10.31M $-132.05M $34.15M $36.49M $36.32M $30.06M $36.26M
Income Before Tax Ratio 25.82% 16.59% 13.67% 15.51% 10.74% -9.06% 13.35% -5.43% -51.41% -35.15% 10.94% 25.07% -17.56% 8.02% -86.35% 22.41% 24.00% 25.36% 19.53% 24.28%
Income Tax Expense $380.00K $-265.00K $437.00K $453.00K $493.00K $455.00K $326.00K $728.00K $124.00K $579.00K $255.00K $284.00K $531.00K $92.00K $522.00K $700.00K $-627.00K $-138.00K $433.00K $1.04M
Net Income $46.70M $29.79M $23.98M $26.25M $17.16M $-15.10M $21.19M $-9.49M $-84.95M $-50.06M $16.80M $40.60M $-24.35M $10.22M $-132.57M $33.45M $37.12M $36.46M $29.62M $35.22M
Net Income Ratio 25.61% 16.73% 13.43% 15.25% 10.44% -9.34% 13.15% -5.88% -51.49% -35.57% 10.78% 24.89% -17.95% 7.95% -86.69% 21.95% 24.41% 25.45% 19.25% 23.58%
EPS $0.20 $0.13 $0.10 $0.11 $0.07 $-0.07 $0.09 $-0.04 $-0.37 $-0.22 $0.07 $0.18 $-0.11 $0.05 $-0.62 $0.16 $0.18 $0.18 $0.14 $0.17
EPS Diluted $0.19 $0.13 $0.10 $0.11 $0.07 $-0.07 $0.09 $-0.04 $-0.37 $-0.22 $0.07 $0.18 $-0.11 $0.05 $-0.61 $0.16 $0.18 $0.18 $0.14 $0.17
Weighted Average Shares Outstanding 236.60M 234.29M 231.62M 231.45M 231.22M 231.22M 231.20M 231.16M 230.99M 230.98M 230.97M 230.86M 219.31M 220.87M 214.42M 211.45M 208.10M 205.79M 205.59M 205.40M
Weighted Average Shares Outstanding Diluted 239.64M 237.04M 233.75M 233.37M 233.20M 231.22M 232.24M 231.16M 230.99M 230.98M 231.68M 231.56M 227.52M 222.06M 216.26M 212.62M 209.32M 206.73M 206.22M 206.01M
SEC Filing Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source

Annual Balance Sheet

Breakdown December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Cash and Cash Equivalents $60.47M $41.28M $49.31M $112.00M $59.08M
Short Term Investments $- $18.92M $411.40M $3.33M $12.80M
Cash and Short Term Investments $60.47M $41.28M $49.31M $112.00M $59.08M
Net Receivables $131.75M $103.29M $147.91M $480.14M $219.54M
Inventory $- $- $411.40M $119.78M $71.97M
Other Current Assets $5.87M $68.13M $-411.40M $3.89M $6.45M
Total Current Assets $192.22M $212.70M $613.24M $653.08M $329.01M
Property Plant Equipment Net $- $- $4.96B $5.16B $5.29B
Goodwill $- $- $- $- $-
Intangible Assets $27.46M $30.90M $40.13M $54.06M $82.80M
Goodwill and Intangible Assets $27.46M $30.90M $40.13M $54.06M $82.80M
Long Term Investments $182.92M $194.69M $134.96M $96.68M $288.76M
Tax Assets $- $- $-4.96B $-5.16B $-5.29B
Other Non-Current Assets $4.51B $4.62B $4.96B $5.16B $5.29B
Total Non-Current Assets $4.72B $4.84B $5.13B $5.31B $5.66B
Other Assets $387.34M $330.60M $- $- $-
Total Assets $5.30B $5.39B $5.75B $5.97B $5.99B
Account Payables $- $73.79M $142.26M $142.99M $72.16M
Short Term Debt $1.76B $96.46M $196.98M $17.48M $18.42M
Tax Payables $- $- $- $- $-
Deferred Revenue $- $- $- $- $-72.16M
Other Current Liabilities $- $61.16M $-196.98M $1.62B $1.22B
Total Current Liabilities $1.76B $231.41M $142.26M $142.99M $146.28M
Long Term Debt $26.85M $2.35B $2.55B $2.43B $2.41B
Deferred Revenue Non-Current $- $- $2.69B $2.59B $2.58B
Deferred Tax Liabilities Non-Current $- $- $42.24M $49.71M $57.73M
Other Non-Current Liabilities $772.67M $- $-1.63B $-1.62B $-1.14B
Total Non-Current Liabilities $799.52M $2.35B $2.55B $2.44B $2.43B
Other Liabilities $- $- $- $- $-
Total Liabilities $2.56B $2.58B $2.69B $2.59B $2.58B
Preferred Stock $- $- $- $- $-
Common Stock $2.38M $2.31M $2.31M $2.30M $2.11M
Retained Earnings $- $-1.72B $-1.45B $-1.10B $-716.20M
Accumulated Other Comprehensive Income Loss $20.94M $963.00K $19.06M $-10.02M $-39.91M
Other Total Stockholders Equity $2.72B $4.52B $4.49B $4.48B $4.16B
Total Stockholders Equity $2.74B $2.80B $3.06B $3.38B $3.41B
Total Equity $2.74B $2.80B $5.55B $5.71B $5.77B
Total Liabilities and Stockholders Equity $5.30B $5.39B $5.75B $5.97B $5.99B
Minority Interest $- $- $2.50B $2.33B $2.36B
Total Liabilities and Total Equity $5.30B $5.39B $5.75B $5.97B $5.99B
Total Investments $182.92M $213.61M $597.43M $96.68M $288.76M
Total Debt $1.76B $2.45B $2.70B $2.39B $2.37B
Net Debt $1.70B $2.41B $2.65B $2.28B $2.31B


Balance Sheet Charts

Breakdown December 31, 2024 September 30, 2024 June 30, 2024 March 31, 2024 December 31, 2023 September 30, 2023 June 30, 2023 March 31, 2023 December 31, 2022 September 30, 2022 June 30, 2022 March 31, 2022 December 31, 2021 September 30, 2021 June 30, 2021 March 31, 2021 December 31, 2020 September 30, 2020 June 30, 2020 March 31, 2020
Cash and Cash Equivalents $60.47M $63.00M $42.31M $65.93M $46.72M $33.26M $27.23M $33.53M $49.31M $26.29M $67.15M $24.84M $112.00M $546.34M $69.35M $24.88M $59.08M $35.03M $28.25M $54.05M
Short Term Investments $- $- $-57.33M $27.14M $18.92M $39.33M $31.12M $19.82M $411.40M $22.76M $395.34M $- $57.05M $- $- $- $- $- $- $-
Cash and Short Term Investments $60.47M $63.00M $42.31M $65.93M $46.72M $33.26M $27.23M $33.53M $49.31M $26.29M $67.15M $24.84M $112.00M $546.34M $69.35M $24.88M $59.08M $35.03M $28.25M $54.05M
Net Receivables $131.75M $121.46M $527.82M $511.05M $496.58M $513.26M $507.93M $489.10M $147.91M $490.21M $516.95M $496.59M $480.14M $191.81M $235.85M $244.84M $219.54M $221.01M $217.47M $232.22M
Inventory $- $- $335.19M $59.93M $46.72M $44.46M $37.53M $43.84M $411.40M $-22.76M $395.34M $- $- $- $- $- $- $- $- $-
Other Current Assets $5.87M $5.97M $5.91M $6.00M $- $5.60M $5.15M $5.15M $-411.40M $4.86M $4.37M $4.44M $3.89M $5.08M $4.59M $4.61M $6.45M $6.82M $8.55M $8.38M
Total Current Assets $192.22M $184.46M $570.13M $576.98M $543.30M $609.04M $540.30M $580.50M $613.24M $521.36M $588.47M $525.87M $653.08M $743.23M $309.78M $274.33M $329.01M $262.86M $254.27M $294.65M
Property Plant Equipment Net $- $- $4.57B $4.59B $4.63B $4.60B $4.75B $4.80B $4.96B $5.02B $5.05B $5.16B $5.16B $5.23B $5.27B $5.28B $5.29B $5.31B $5.36B $5.36B
Goodwill $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Intangible Assets $27.46M $28.79M $27.72M $28.30M $30.90M $32.75M $35.99M $39.37M $40.13M $48.30M $49.84M $52.88M $54.06M $76.43M $79.65M $81.45M $82.80M $85.94M $93.50M $96.76M
Goodwill and Intangible Assets $27.46M $28.79M $27.72M $28.30M $30.90M $32.75M $35.99M $39.37M $40.13M $48.30M $49.84M $52.88M $54.06M $76.43M $79.65M $81.45M $82.80M $85.94M $93.50M $96.76M
Long Term Investments $182.92M $- $187.10M $218.98M $213.61M $135.75M $196.14M $139.40M $134.96M $256.36M $277.99M $150.13M $96.68M $161.21M $163.26M $328.61M $288.76M $336.55M $317.26M $337.73M
Tax Assets $- $- $37.18M $-4.59B $-4.63B $-4.60B $-4.75B $-4.80B $-4.96B $-408.62M $-5.05B $-5.16B $-5.16B $-5.23B $-5.27B $-5.28B $-5.29B $-5.31B $-5.36B $-5.36B
Other Non-Current Assets $4.51B $- $-37.18M $4.55B $4.60B $4.60B $4.75B $4.80B $4.96B $- $5.05B $5.16B $5.16B $5.23B $5.27B $5.28B $5.29B $5.31B $5.36B $5.36B
Total Non-Current Assets $4.72B $28.79M $4.78B $4.80B $4.84B $4.77B $4.98B $4.98B $5.13B $5.32B $5.37B $5.36B $5.31B $5.47B $5.51B $5.69B $5.66B $5.73B $5.77B $5.80B
Other Assets $387.34M $5.15B $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Total Assets $5.30B $5.37B $5.35B $5.37B $5.39B $5.38B $5.52B $5.56B $5.75B $5.84B $5.96B $5.88B $5.97B $6.21B $5.82B $5.96B $5.99B $5.99B $6.02B $6.09B
Account Payables $- $- $112.83M $59.04M $73.79M $78.34M $121.86M $94.00M $142.26M $109.32M $117.68M $118.30M $142.99M $- $- $123.50M $- $143.74M $143.32M $150.93M
Short Term Debt $1.76B $- $1.02M $1.53M $196.63M $32.62M $996.00K $79.56M $196.98M $- $- $- $17.48M $16.28M $17.42M $17.90M $18.42M $655.00K $1.61M $2.39M
Tax Payables $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Deferred Revenue $- $- $129.34M $-59.04M $-73.79M $-78.34M $- $-94.00M $- $- $- $- $- $- $- $- $- $- $- $-
Other Current Liabilities $- $1.76B $1.65B $42.30M $1.50B $1.66B $1.65B $1.60B $-196.98M $35.90M $- $- $1.62B $2.07B $1.28B $1.16B $1.29B $1.16B $1.17B $1.16B
Total Current Liabilities $1.76B $1.76B $112.83M $258.89M $231.41M $160.66M $121.86M $222.56M $142.26M $145.22M $117.68M $118.30M $142.99M $126.83M $119.42M $123.50M $146.28M $143.74M $143.32M $150.93M
Long Term Debt $26.85M $2.50B $2.48B $2.49B $2.25B $2.35B $2.46B $2.36B $2.35B $2.49B $2.53B $2.41B $2.44B $2.75B $2.32B $2.34B $2.43B $2.48B $2.52B $2.55B
Deferred Revenue Non-Current $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Deferred Tax Liabilities Non-Current $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Other Non-Current Liabilities $772.67M $513.00K $1.02M $11.43M $102.21M $- $996.00K $- $- $- $- $- $- $- $- $- $- $- $- $-
Total Non-Current Liabilities $799.52M $2.50B $2.48B $2.35B $2.35B $2.35B $2.46B $2.36B $2.55B $2.49B $2.53B $2.41B $2.44B $2.75B $2.32B $2.34B $2.43B $2.48B $2.52B $2.55B
Other Liabilities $- $-1.64B $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Total Liabilities $2.56B $2.62B $2.59B $2.61B $2.58B $2.51B $2.58B $2.58B $2.69B $2.64B $2.64B $2.52B $2.59B $2.88B $2.44B $2.46B $2.58B $2.63B $2.66B $2.70B
Preferred Stock $- $- $32.35M $29.42M $20.47M $1.67B $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Common Stock $2.38M $2.37M $2.34M $2.31M $2.31M $2.31M $2.31M $2.31M $2.31M $2.31M $2.31M $2.31M $2.30M $2.21M $2.21M $2.16M $2.11M $2.07M $2.06M $2.06M
Retained Earnings $- $-1.85B $-1.81B $-1.76B $-1.72B $-1.67B $-1.58B $-1.53B $-1.45B $-1.30B $-1.18B $-1.12B $-1.10B $-1.00B $-944.50M $-746.52M $-716.20M $-689.83M $-663.90M $-631.25M
Accumulated Other Comprehensive Income Loss $20.94M $16.94M $-1.21M $-535.00K $963.00K $39.67M $32.24M $17.44M $19.06M $18.52M $10.14M $1.67M $-10.02M $-16.14M $-16.17M $-6.37M $-39.91M $-49.17M $-55.64M $-51.37M
Other Total Stockholders Equity $2.72B $4.57B $6.34B $6.26B $6.21B $4.49B $4.49B $4.49B $5.94B $4.48B $4.48B $4.48B $4.48B $4.34B $4.34B $4.25B $4.16B $4.10B $4.08B $4.08B
Total Stockholders Equity $2.74B $2.74B $2.76B $2.77B $2.80B $2.87B $2.94B $2.98B $3.06B $3.21B $3.32B $3.36B $3.38B $3.33B $3.38B $3.50B $3.41B $3.36B $3.36B $3.40B
Total Equity $2.74B $2.74B $2.76B $2.77B $2.80B $2.87B $2.94B $2.98B $3.06B $3.21B $3.32B $3.36B $3.38B $3.33B $3.38B $3.50B $3.41B $3.36B $3.36B $3.40B
Total Liabilities and Stockholders Equity $5.30B $5.37B $5.35B $5.37B $5.39B $5.38B $5.52B $5.56B $5.75B $5.84B $5.96B $5.88B $5.97B $6.21B $5.82B $5.96B $5.99B $5.99B $6.02B $6.09B
Minority Interest $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Total Liabilities and Total Equity $5.30B $5.37B $5.35B $5.37B $5.39B $5.38B $5.52B $5.56B $5.75B $5.84B $5.96B $5.88B $5.97B $6.21B $5.82B $5.96B $5.99B $5.99B $6.02B $6.09B
Total Investments $182.92M $- $129.77M $218.98M $213.61M $135.75M $196.14M $139.40M $597.43M $279.12M $673.34M $150.13M $153.74M $161.21M $163.26M $328.61M $288.76M $336.55M $317.26M $337.73M
Total Debt $1.76B $2.50B $2.48B $2.49B $2.45B $2.35B $2.42B $2.40B $2.70B $2.45B $2.48B $2.36B $2.39B $2.70B $2.27B $2.28B $2.37B $2.42B $2.46B $2.48B
Net Debt $1.70B $2.44B $2.43B $2.43B $2.40B $2.32B $2.39B $2.36B $2.65B $2.42B $2.41B $2.33B $2.28B $2.16B $2.20B $2.26B $2.31B $2.39B $2.43B $2.43B

Annual Cash Flow

Breakdown December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Net Income $126.71M $13.76M $-77.61M $-113.26M $138.42M
Depreciation and Amortization $169.62M $183.09M $187.78M $178.99M $176.74M
Deferred Income Tax $- $- $- $227.84M $32.92M
Stock Based Compensation $8.99M $7.92M $7.45M $7.91M $7.91M
Change in Working Capital $- $-2.73M $-19.69M $22.70M $-2.74M
Accounts Receivables $-15.46M $-11.08M $-6.44M $8.22M $-6.40M
Inventory $- $11.08M $6.44M $-8.22M $6.40M
Accounts Payables $-7.09M $8.34M $-13.25M $14.48M $3.66M
Other Working Capital $- $-11.08M $-6.44M $8.22M $-6.40M
Other Non Cash Items $5.22M $98.55M $217.80M $32.20M $1.61M
Net Cash Provided by Operating Activities $310.54M $300.57M $315.73M $356.39M $354.85M
Investments in Property Plant and Equipment $- $- $- $-33.61M $-105.59M
Acquisitions Net $- $-5.24M $-142.91M $-7.77M $-16.65M
Purchases of Investments $- $-11.02M $-8.02M $-9.06M $-20.07M
Sales Maturities of Investments $- $- $5.38M $1.29M $3.42M
Other Investing Activities $-109.00M $119.39M $-70.69M $-287.05M $2.44M
Net Cash Used for Investing Activities $-109.00M $103.13M $-216.25M $-336.20M $-136.45M
Debt Repayment $12.56M $-94.13M $122.78M $23.86M $-3.07M
Common Stock Issued $86.12M $- $- $308.71M $80.09M
Common Stock Repurchased $- $-2.68M $-4.81M $- $-
Dividends Paid $-280.15M $-277.45M $-277.16M $-262.92M $-278.30M
Other Financing Activities $-94.00K $-36.04M $-2.52M $-39.51M $-830.00K
Net Cash Used Provided by Financing Activities $-181.56M $-410.30M $-161.71M $30.14M $-202.11M
Effect of Forex Changes on Cash $-359.00K $-614.00K $268.00K $29.00K $88.00K
Net Change in Cash $19.62M $-7.21M $-61.95M $50.36M $16.38M
Cash at End of Period $66.34M $46.72M $53.93M $115.89M $65.52M
Cash at Beginning of Period $46.72M $53.93M $115.89M $65.52M $49.14M
Operating Cash Flow $310.54M $300.57M $315.73M $356.39M $354.85M
Capital Expenditure $- $- $- $-33.61M $-105.59M
Free Cash Flow $310.54M $300.57M $315.73M $322.78M $249.26M

Cash Flow Charts

Breakdown December 31, 2024 September 30, 2024 June 30, 2024 March 31, 2024 December 31, 2023 September 30, 2023 June 30, 2023 March 31, 2023 December 31, 2022 September 30, 2022 June 30, 2022 March 31, 2022 December 31, 2021 September 30, 2021 June 30, 2021 March 31, 2021 December 31, 2020 September 30, 2020 June 30, 2020 March 31, 2020
Net Income $46.70M $29.79M $23.98M $26.25M $17.16M $-15.10M $21.19M $-9.49M $-84.95M $-50.06M $16.80M $40.60M $-24.35M $10.22M $-132.57M $33.45M $37.12M $36.46M $29.62M $35.22M
Depreciation and Amortization $42.31M $42.72M $41.68M $42.91M $42.88M $43.24M $44.14M $52.83M $49.93M $47.43M $45.17M $45.26M $45.08M $45.05M $44.49M $44.38M $44.16M $44.21M $44.20M $44.17M
Deferred Income Tax $- $- $- $- $-82.87M $48.11M $9.66M $- $- $- $- $- $43.09M $4.75M $173.49M $6.51M $7.00M $1.96M $15.37M $8.59M
Stock Based Compensation $2.54M $2.59M $1.34M $2.52M $2.45M $2.23M $1.00M $2.23M $2.09M $2.12M $794.00K $2.46M $927.00K $2.43M $2.27M $2.29M $2.26M $916.00K $2.38M $2.36M
Change in Working Capital $-6.75M $29.69M $-2.05M $-27.64M $4.91M $6.65M $-5.67M $-8.62M $-16.22M $28.50M $-5.54M $-26.43M $15.04M $21.80M $-273.00K $-13.87M $3.38M $3.94M $6.77M $-16.82M
Accounts Receivables $- $-4.88M $-2.42M $-6.29M $-418.00K $-4.38M $-3.50M $-2.78M $-812.00K $443.00K $-617.00K $-5.46M $-4.84M $15.42M $512.00K $-2.87M $-2.88M $-2.15M $5.52M $-6.89M
Inventory $- $- $- $- $418.00K $-11.03M $2.18M $- $- $- $4.93M $20.97M $- $- $- $- $- $- $- $-
Accounts Payables $- $18.77M $364.00K $-21.35M $5.33M $11.03M $-2.18M $-5.84M $-13.25M $- $-4.93M $-20.97M $19.88M $6.37M $-785.00K $-10.99M $6.25M $6.09M $1.25M $-9.93M
Other Working Capital $-6.75M $15.80M $-2.42M $-6.29M $-418.00K $11.03M $-2.18M $8.62M $-2.16M $- $-4.93M $-20.97M $-4.84M $15.42M $512.00K $-2.87M $- $- $- $-
Other Non Cash Items $-4.83M $-7.13M $99.52M $118.44M $94.21M $-1.92M $10.00K $31.34M $116.75M $15.24M $19.34M $1.23M $18.14M $21.95M $-3.67M $-4.23M $-4.51M $9.37M $-4.55M $1.31M
Net Cash Provided by Operating Activities $79.97M $97.65M $80.13M $52.80M $78.74M $83.22M $70.33M $68.29M $67.59M $108.46M $76.57M $63.11M $97.93M $106.19M $83.73M $68.53M $89.40M $96.85M $93.79M $74.82M
Investments in Property Plant and Equipment $- $- $- $- $5.27M $-80.63M $-21.26M $- $- $- $128.74M $-729.00K $39.25M $-277.00K $- $- $-23.60M $- $- $-
Acquisitions Net $-5.86M $344.00K $-156.00K $-188.00K $-5.27M $4.83M $-1.43M $-4.80M $-14.89M $-12.00K $-128.74M $729.00K $-4.30M $-589.00K $-3.18M $301.00K $16.66M $-19.72M $5.00K $3.06M
Purchases of Investments $-303.00K $-1.51M $-68.37M $-14.23M $-62.21M $-339.00K $-4.29M $-6.38M $-2.21M $-823.00K $-916.00K $-4.07M $-4.91M $-759.00K $-47.75M $-39.49M $-10.00K $-20.06M $- $-
Sales Maturities of Investments $- $- $11.07M $1.01M $-24.86M $80.63M $21.26M $1.43M $1.20M $2.84M $604.00K $729.00K $609.00K $170.00K $212.00K $301.00K $20.00K $335.00K $5.00K $3.06M
Other Investing Activities $24.73M $-55.87M $-18.85M $289.00K $25.29M $55.44M $-2.47M $122.92M $-15.26M $-4.08M $-90.55M $-33.90M $-289.48M $1.30M $-38.88M $-35.96M $998.00K $-12.16M $-29.15M $-75.94M
Net Cash Used for Investing Activities $18.56M $-57.03M $-57.31M $-13.22M $-61.78M $59.93M $-8.19M $113.17M $-31.16M $-56.99M $-90.86M $-37.24M $-258.83M $-158.00K $-41.85M $-35.36M $-5.93M $-31.55M $-29.14M $-69.82M
Debt Repayment $-44.73M $21.37M $-15.97M $51.90M $60.49M $-66.98M $19.09M $-106.75M $56.21M $-19.23M $125.30M $-39.50M $-310.48M $445.78M $-17.74M $-93.71M $-56.68M $-17.82M $-28.80M $100.12M
Common Stock Issued $- $34.96M $- $- $-1.18M $- $- $- $- $- $- $- $136.53M $-510.00K $85.04M $87.65M $59.13M $19.10M $-70.00K $1.93M
Common Stock Repurchased $- $- $- $-2.61M $- $- $-306.00K $-1.85M $-416.00K $-591.00K $-55.00K $-3.75M $- $- $- $- $- $- $- $-
Dividends Paid $-70.98M $-70.28M $-69.45M $-69.44M $-69.37M $-69.37M $-69.36M $-69.35M $-69.30M $-69.30M $-69.29M $-69.28M $-68.61M $-66.26M $-64.83M $-63.22M $-62.55M $-61.68M $-61.68M $-92.39M
Other Financing Activities $-14.00K $- $- $-80.00K $- $-7.00K $-17.90M $-18.13M $-14.00K $-2.50M $- $- $-32.07M $-7.44M $-7.00K $- $-11.00K $- $- $-715.00K
Net Cash Used Provided by Financing Activities $-100.96M $-13.96M $-46.41M $-20.23M $-9.36M $-136.39M $-68.47M $-196.07M $-13.52M $-91.62M $55.95M $-112.52M $-274.63M $371.57M $2.47M $-69.28M $-60.11M $-60.40M $-90.55M $8.95M
Effect of Forex Changes on Cash $-201.00K $2.00K $-29.00K $-131.00K $266.00K $-272.00K $33.00K $-641.00K $-124.00K $-227.00K $579.00K $40.00K $-5.00K $-125.00K $94.00K $65.00K $318.00K $146.00K $284.00K $-660.00K
Net Change in Cash $-2.64M $26.67M $-23.62M $19.21M $7.86M $6.48M $-6.30M $-15.25M $22.78M $-40.37M $42.24M $-86.61M $-435.53M $477.48M $44.45M $-36.04M $23.67M $5.04M $-25.62M $13.28M
Cash at End of Period $66.34M $68.98M $42.31M $65.93M $46.72M $38.86M $32.38M $38.68M $53.93M $31.15M $71.52M $29.28M $115.89M $551.42M $73.94M $29.49M $65.52M $41.85M $36.80M $62.43M
Cash at Beginning of Period $68.98M $42.31M $65.93M $46.72M $38.86M $32.38M $38.68M $53.93M $31.15M $71.52M $29.28M $115.89M $551.42M $73.94M $29.49M $65.52M $41.85M $36.80M $62.43M $49.14M
Operating Cash Flow $79.97M $97.65M $80.13M $52.80M $78.74M $83.22M $70.33M $68.29M $67.59M $108.46M $76.57M $63.11M $97.93M $106.19M $83.73M $68.53M $89.40M $96.85M $93.79M $74.82M
Capital Expenditure $- $- $- $- $5.27M $-80.63M $-21.26M $- $- $- $128.74M $-729.00K $39.25M $-277.00K $- $- $-23.60M $- $- $-
Free Cash Flow $79.97M $97.65M $80.13M $52.80M $84.00M $2.59M $49.07M $68.29M $67.59M $108.46M $205.31M $62.38M $137.18M $105.92M $83.73M $68.53M $65.80M $96.85M $93.79M $74.82M

Sabra Health Care REIT Dividends

Explore Sabra Health Care REIT's dividend history, including dividend yield, payout ratio, and historical payments.

Dividend Yield

6.93%

Dividend Payout Ratio

221.09%

Dividend Paid & Capex Coverage Ratio

1.11x

Sabra Health Care REIT Dividend History

Dividend Adjusted Dividend Date Record Date Payment Date Declaration Date
$0.3 $0.3 February 14, 2025 February 14, 2025 February 28, 2025 February 03, 2025
$0.3 $0.3 November 15, 2024 November 15, 2024 November 29, 2024 October 31, 2024
$0.3 $0.3 August 19, 2024 August 19, 2024 August 30, 2024 August 07, 2024
$0.3 $0.3 May 17, 2024 May 20, 2024 May 31, 2024 May 08, 2024
$0.3 $0.3 February 12, 2024 February 13, 2024 February 29, 2024 February 01, 2024
$0.3 $0.3 November 16, 2023 November 17, 2023 November 30, 2023 November 06, 2023
$0.3 $0.3 August 16, 2023 August 17, 2023 August 31, 2023 August 07, 2023
$0.3 $0.3 May 15, 2023 May 16, 2023 May 31, 2023 May 03, 2023
$0.3 $0.3 February 10, 2023 February 13, 2023 February 28, 2023 February 01, 2023
$0.3 $0.3 November 16, 2022 November 17, 2022 November 30, 2022 November 07, 2022
$0.3 $0.3 August 16, 2022 August 17, 2022 August 31, 2022 August 03, 2022
$0.3 $0.3 May 13, 2022 May 16, 2022 May 31, 2022 May 04, 2022
$0.3 $0.3 February 10, 2022 February 11, 2022 February 28, 2022 February 01, 2022
$0.3 $0.3 November 15, 2021 November 16, 2021 November 30, 2021 November 03, 2021
$0.3 $0.3 August 16, 2021 August 17, 2021 August 31, 2021 August 04, 2021
$0.3 $0.3 May 14, 2021 May 17, 2021 May 28, 2021 May 05, 2021
$0.3 $0.3 February 11, 2021 February 12, 2021 February 26, 2021 February 02, 2021
$0.3 $0.3 November 13, 2020 November 16, 2020 November 30, 2020 November 05, 2020
$0.3 $0.3 August 14, 2020 August 17, 2020 August 31, 2020 August 05, 2020
$0.3 $0.3 May 15, 2020 May 18, 2020 May 29, 2020 May 06, 2020

Sabra Health Care REIT News

Read the latest news about Sabra Health Care REIT, including recent articles, headlines, and updates.

Sabra Health Care REIT, Inc. Announces Chief Investment Officer Transition

TUSTIN, Calif.--(BUSINESS WIRE)---- $CIO #CIO--Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) today announced that Talya Nevo-Hacohen, Sabra's Chief Investment Officer, Treasurer and Executive Vice President, has decided to retire effective December 31, 2025 and Darrin Smith, Sabra's Executive Vice President, Investments, is expected to be elevated to the role of Sabra's Chief Investment Officer effective January 1, 2026. Ms. Nevo-Hacohen is expected to remain in a consulting role with Sabra pursuant.

News image

Sabra Health Care REIT: Come For Income, Stay For Growth

Sabra Health Care REIT, Inc. offers a 6.7% dividend yield, benefiting from strong fundamentals, favorable demographics, and a well-managed balance sheet. Management is guiding for AFFO growth, supported by rising occupancy, stable reimbursement rates, and a robust acquisition pipeline in skilled nursing. SBRA stock trades at a reasonable valuation with a forward P/FFO of 12.2, positioning it for potential market-beating total returns.

News image

7 Stocks I'm Buying As The U.S. Economy Starts To Crack

I emphasize the importance of nonpartisan economic and investment analysis, highlighting how political biases can distort market expectations and investment decisions. Medicaid cuts would likely have little impact on skilled nursing facility REITs, and the current selloff presents a buying opportunity for CareTrust REIT. Single-family rental REITs face challenges from high home prices and mortgage rates, but offer quality rental homes and professional management.

News image

Sabra Health Care REIT, Inc. (SBRA) Q4 2024 Earnings Call Transcript

Sabra Health Care REIT, Inc. (NASDAQ:SBRA ) Q4 2024 Earnings Conference Call February 20, 2025 1:00 PM ET Company Participants Lukas Hartwich - EVP, Finance Rick Matros - CEO, President & Chair Talya Nevo-Hacohen - CIO, Treasurer & EVP Mike Costa - CFO Conference Call Participants Farrell Granath - Bank of America John Kilichowski - Wells Fargo Michael Griffin - Citi Research Austin Wurschmidt - KeyBanc Capital Markets Georgi Dinkov - Mizuho Juan Sanabria - BMO Capital Markets Richard Anderson - Wedbush Alec Feygin - Baird Equity Research Michael Stroyeck - Green Street Aaron Hecht - JMP Securities Omotayo Okusanya - Deutsche Bank Operator Good day. My name is Aaron, and I will be your conference operator for today.

News image

Sabra (SBRA) Reports Q4 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Sabra (SBRA) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

News image

Sabra Healthcare (SBRA) Q4 FFO Match Estimates

Sabra Healthcare (SBRA) came out with quarterly funds from operations (FFO) of $0.36 per share, in line with the Zacks Consensus Estimate. This compares to FFO of $0.33 per share a year ago.

News image

Sabra Reports Fourth Quarter 2024 Results; Introduces 2025 Guidance

TUSTIN, Calif.--(BUSINESS WIRE)-- #4Q24--Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the fourth quarter of 2024. FOURTH QUARTER 2024 RESULTS AND RECENT EVENTS Results per diluted common share for the fourth quarter of 2024 were as follows: Net Income: $0.19 FFO: $0.36 Normalized FFO: $0.35 AFFO: $0.36 Normalized AFFO: $0.36 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.09x Senior Housing - Leased: 1.36x Beh.

News image

Sabra Health Care REIT, Inc. Announces Leadership Promotions

TUSTIN, Calif.--(BUSINESS WIRE)-- #LEADERSHIP--Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced three promotions within its leadership team. Lukas Hartwich has been promoted to Executive Vice President – Finance after previously serving as Senior Vice President – Finance. Since joining Sabra in October 2021, Mr. Hartwich has made notable contributions across the organization, including through his leadership of Sabra's financial planning and analysis, investor rela.

News image

Gear Up for Sabra (SBRA) Q4 Earnings: Wall Street Estimates for Key Metrics

Besides Wall Street's top -and-bottom-line estimates for Sabra (SBRA), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2024.

News image

Sabra Health Care REIT, Inc. Announces Fourth Quarter 2024 Earnings Release Date and Conference Call; Declares Common Dividend

TUSTIN, Calif.--(BUSINESS WIRE)-- #4Q24--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2024 fourth quarter earnings release on February 19, 2025, after the close of trading. A conference call with a simultaneous webcast to discuss the 2024 fourth quarter results will be held on Thursday, February 20 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conferen.

News image

Jefferies Loves 5 High-Yield Healthcare REITs in 2025 for Growth and Income

While the December interest rate cut of 25 basis points may be the last for a while, it is an excellent bet that federal funds will be lower than today's effective rate of 4.23%, and below the long-term average of 4.61%.

News image

Sabra Health Care REIT, Inc. Announces Tax Treatment of 2024 Distributions

TUSTIN, Calif.--(BUSINESS WIRE)-- #dividends--Sabra Health Care REIT, Inc. (NASDAQ: SBRA) announced today the tax treatment for its 2024 distributions. The following table summarizes, for income tax purposes, the nature of cash distributions paid: Sabra Health Care REIT, Inc. Common Stock (CUSIP # 78573L106) Record Date   Payable Date Distribution per Share   Total Ordinary Dividends   Non-Qualified Dividends   Qualified Dividends   Non-Dividend Distributions 02/13/2024   02/29/2024 $ 0.3000000     $ 0.2649.

News image

CHCT vs. SBRA: Which Stock Is the Better Value Option?

Investors interested in REIT and Equity Trust - Other stocks are likely familiar with Community Healthcare Trust (CHCT) and Sabra Healthcare (SBRA). But which of these two stocks presents investors with the better value opportunity right now?

News image

Sabra Health Care REIT: Buy Into Future Demand For Skilled Nursing Facilities

Sabra Health Care REIT gets rated buy, agreeing with consensus, and driven heavily by macro-level demand forecasts for skilled nursing facilities. The stock is undervalued on forward P/FFO vs key peers, and is trading close to its moving average now. The firm has investment-grade ratings from Fitch and Moody's agencies.

News image

Sabra Health Care REIT: A High-Yielding Gift Just In Time For The New Year

With the FED's rate cut predictions for 2025, Sabra Health Care REIT offers a buying opportunity for long-term investors, especially retirees and income investors. Sabra's solid fundamentals, including improved occupancy rates and a safe 6% dividend yield, make it an attractive investment despite recent market sell-offs. The REIT's balance sheet has strengthened, with Moody's upgrading their outlook to positive, indicating potential for future investment opportunities and price appreciation.

News image

Sabra (SBRA) Upgraded to Buy: Here's Why

Sabra (SBRA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

News image

Sabra Health Care REIT: A Promising Value Play In Healthcare Real Estate

Sabra Health Care REIT offers a compelling investment opportunity with a reasonable valuation, trading at 13.6x 2024 FFO and 12.9x 2025 FFO. The company benefits from strong industry fundamentals, including an aging population and growing demand for senior living and healthcare facilities. Q3'24 results showed robust performance with occupancy gains and NOI growth, particularly in the SHOP portfolio, indicating effective operational leverage.

News image

Sabra Health Care REIT, Inc. to Attend Nareit's REITworld 2024 Annual Conference

TUSTIN, Calif.--(BUSINESS WIRE)-- #REITworld--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the company's Chief Financial Officer, Darrin Smith, the company's Executive Vice President of Investments, and Lukas Hartwich, the company's Senior Vice President of Finance, will attend Nareit's REITworld 2024 Annual Conference on November 19-20, 2024 at the Wynn Las Vegas in Las Vegas, Nevada. About Sabra Sabra Health C.

News image

Sabra Health Care REIT, Inc. (SBRA) Q3 2024 Earnings Call Transcript

Sabra Health Care REIT, Inc. (NASDAQ:SBRA ) Q3 2024 Earnings Conference Call November 1, 2024 1:00 PM ET Company Participants Lukas Hartwich - Senior Vice President, Finance Rick Matros - Chief Executive Officer, President & Chair of the Board Talya Nevo-Hacohen - Chief Investment Officer, Treasurer & Executive Vice President Michael Costa - Chief Financial Officer Conference Call Participants Elmer Chang - Scotiabank John Kilichowski - Wells Fargo Austin Wurschmidt - KeyBanc Juan Sanabria - BMO Capital Michael Griffin - Citi Rich Anderson - Wedbush Alec Feygin - Baird Michael Stroyeck - Green Street Omotayo Okusanya - Deutsche Bank Operator Good day, everyone. My name is Adam, and I will be your conference operator today.

News image

Sabra (SBRA) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Sabra (SBRA) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

News image

Sabra Healthcare (SBRA) Q3 FFO and Revenues Surpass Estimates

Sabra Healthcare (SBRA) came out with quarterly funds from operations (FFO) of $0.37 per share, beating the Zacks Consensus Estimate of $0.36 per share. This compares to FFO of $0.34 per share a year ago.

News image

Moody's Upgrades Sabra Health Care REIT, Inc.'s Outlook to Positive, Affirms Credit Rating

TUSTIN, Calif.--(BUSINESS WIRE)-- #Moodys--Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) announced today that Moody's Ratings (“Moody's”) issued a report on October 17, 2024 affirming Sabra's Ba1 ratings and upgrading Sabra's outlook to “Positive” from “Stable”. The report credits Sabra's upgraded outlook to improving industry fundamentals for skilled nursing and senior housing, which is driving an improvement in Sabra's key credit metrics, particularly net debt to EBITDA. For additional informat.

News image

Sabra Health Care REIT, Inc. Announces Third Quarter 2024 Earnings Release Date and Conference Call

TUSTIN, Calif.--(BUSINESS WIRE)-- #3Q24--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2024 third quarter earnings release on October 31, 2024, after the close of trading. A conference call with a simultaneous webcast to discuss the 2024 third quarter results will be held on Friday, November 1 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID.

News image

Sabra Health Care REIT, Inc. to Attend Fall Conferences

TUSTIN, Calif.--(BUSINESS WIRE)-- #asha--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Darrin Smith, the company's Executive Vice President of Investments, Eliza Gozar, the company's Senior Vice President of Investments, and Lauren Nisley, the company's Director of Investments, will attend the INVEST Conference on October 7-9, 2024 at the JW Marriott Dallas Arts District in Dallas, Texas. Talya Nevo-Hacohen, the company's.

News image

Sabra Health Care REIT: Turning The Corner

Sabra Healthcare REIT is showing a strong turnaround with impressive Q2 earnings, driven by increased occupancy and NOI growth, particularly in senior housing. The REIT's deleveraging efforts and strong liquidity position it well for future investments, with no debt maturing before 2026 and investment-grade ratings. Dividend growth is expected to resume in 2025, with management raising AFFO guidance, suggesting potential for share price appreciation despite lagging peers.

News image

10 Sweet REITs: Yield Up To 6.6%

Equity REITs, distinct from mortgage REITs, generate income from rental leases and capital appreciation, offering high yields and tax advantages by distributing 90% of taxable income. My portfolio, Rose's Income Garden (RIG), includes six of the ten highlighted REITs, chosen for their credit ratings, yields, and growth potential. Interest rates significantly impact REIT prices; current high valuations may not last, but lower rates could enhance future pricing and investment opportunities.

News image

Sabra Health Care REIT, Inc. to Participate in the BofA Securities 2024 Global Real Estate Conference

TUSTIN, Calif.--(BUSINESS WIRE)-- #BAML--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the company's Chief Financial Officer, Talya Nevo-Hacohen, the company's Chief Investment Officer, Darrin Smith, the company's Executive Vice President of Investments, and Lukas Hartwich, the company's Senior Vice President of Finance, will participate in the BofA Securities 2024 Global Real Estate Conference on September.

News image

Sabra Health Care REIT, Inc. (SBRA) Q2 2024 Earnings Call Transcript

Sabra Health Care REIT, Inc. (NASDAQ:SBRA ) Q2 2024 Earnings Conference Call August 8, 2024 1:00 PM ET Company Participants Lukas Hartwich - Senior Vice President, Finance Rick Matros - Chief Executive Officer, President & Chair of the Board Talya Nevo-Hacohen - Chief Investment Officer, Treasurer & Executive Vice President Michael Costa - Chief Financial Officer Conference Call Participants Elmer Chang - Scotiabank Austin Wurschmidt - KeyBanc Capital Markets Joshua Dennerlein - Bank of America Michael Griffin - Citigroup Vikram Malhotra - Mizuho Securities John Pawlowski - Wells Fargo Rich Anderson - Wedbush Securities Michael Stroyeck - Green Street Advisors, LLC Alec Feygin - Baird Equity Research Operator Good day, everyone. My name is Christina, and I will be your conference operator today.

News image

Sabra (SBRA) Reports Q2 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Sabra (SBRA) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

News image

Sabra Healthcare (SBRA) Q2 FFO and Revenues Top Estimates

Sabra Healthcare (SBRA) came out with quarterly funds from operations (FFO) of $0.36 per share, beating the Zacks Consensus Estimate of $0.35 per share. This compares to FFO of $0.34 per share a year ago.

News image

Similar Companies

C
Community Healthcare Trust Incorporated

CHCT

Price: $18.25

Market Cap: $517.19M

C
CareTrust REIT, Inc.

CTRE

Price: $28.96

Market Cap: $5.43B

D
Healthpeak Properties, Inc.

DOC

Price: $20.19

Market Cap: $14.10B

G
Global Medical REIT Inc.

GMRE

Price: $8.74

Market Cap: $584.45M

H
Healthcare Realty Trust Incorporated

HR

Price: $16.76

Market Cap: $5.88B

L
LTC Properties, Inc.

LTC

Price: $35.25

Market Cap: $1.60B

M
Medical Properties Trust, Inc.

MPW

Price: $6.04

Market Cap: $3.63B

N
National Health Investors, Inc.

NHI

Price: $74.70

Market Cap: $3.41B

P
Healthpeak Properties, Inc.

PEAK

Price: $17.10

Market Cap: $9.36B

U
Universal Health Realty Income Trust

UHT

Price: $40.78

Market Cap: $564.83M

W
Welltower Inc.

WELL

Price: $153.42

Market Cap: $98.39B

Related Metrics

Explore detailed financial metrics and analysis for SBRA.